Among them, compounds 1g–i provided the most promising results in terms of activity against AML cell lines, stabilization of c-MYC, BCL-2 and K-RAS promoter G-quadruplexes and inhibition of telomerase activity. The gene discussed is MYC; the disease is acute myeloid leukemia.